|
Volumn 61, Issue 24, 2001, Pages 8654-8658
|
A Xeroderma Pigmentosum Group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
FLUOROURACIL;
OXALIPLATIN;
ADULT;
ADVANCED CANCER;
AGED;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RISK;
COLORECTAL CANCER;
DNA REPAIR;
FEMALE;
GENETIC POLYMORPHISM;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
XERODERMA PIGMENTOSUM;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CODON;
COLORECTAL NEOPLASMS;
DNA HELICASES;
DNA REPAIR;
DNA-BINDING PROTEINS;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
POLYMORPHISM, GENETIC;
PREDICTIVE VALUE OF TESTS;
PROTEINS;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TRANSCRIPTION FACTORS;
TREATMENT OUTCOME;
XERODERMA PIGMENTOSUM GROUP D PROTEIN;
|
EID: 0035893755
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (281)
|
References (20)
|